1,600 patients undergoing surgery to treat an open fracture, have found that orthopedic surgeons’ choice of antiseptic skin preparation solution does not impact the risk of surgical site infection.
The authors argue that liquid biopsy is not merely an innovation in biomarker detection, it is a methodological bridge that aligns molecular biology with patient-centered care.